The Study of Relationship of Plasma Concentrations of Folic Acid, Vitamin B and Homocysteine With Carotid Atherosclerosis and Endothelium-Dependent Vasodilatation of Geriatric and Young Patients in the Ambulatory Care Department of NTUH
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00172250|
Recruitment Status : Completed
First Posted : September 15, 2005
Last Update Posted : November 24, 2005
Elevation of plasma homocysteine has been recognized as one of the risk factors of atherosclerotic disease. The objectives of this study are: (1) to investigate the level of plasma homocysteine and the prevalence of hypehomocysteinemia (2) to find out the role of homocysteine in coronary artery disease and the proper cut-off point of plasma homocysteine to evaluate the presence of coronary artery disease; (3) to understand the control condition of tranditional risk factors of cardiovascular disease, especially hypertension, dyslipidemia, and diabetes mellitus.
The study subjects were recruited from the ambulatory setting of cardiology in National Taiwan University Hospital.
|Condition or disease|
|Homocysteine Coronary Artery Disease|
|Study Type :||Observational|
|Observational Model:||Case Control|
|Study Start Date :||September 2003|
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00172250
|Principal Investigator:||Juey-Jen Hwang, MD, PhD||National Taiwan University Hospital|